Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder in which the body cannot properly break down three amino acids: leucine, isoleucine, and valine. These are called branched-chain amino acids (BCAAs). When MSUD is not managed, these amino acids and their byproducts can build up in the blood and become harmful, especially to the brain and nervous system.

 

Important: MSUD can vary in severity. Some people are diagnosed through newborn screening and begin treatment immediately, while others may be diagnosed later. Your metabolic clinic will confirm the type of MSUD, explain what it means, and guide a plan.

 

Jump to: What is MSUD? | Why early detection matters | Living with MSUD | Tools | Where to go next

 

 

MSUD is caused by changes in genes that affect an enzyme complex called branched-chain alpha-keto acid dehydrogenase (BCKD). This enzyme complex normally helps the body break down leucine, isoleucine, and valine.

 

In MSUD, the BCKD enzyme complex is absent or does not work well. As a result, BCAAs and their byproducts can rise to unsafe levels. MSUD is named for a distinctive “sweet” odour that can be noticed in urine, sweat, or earwax in some cases.

 

Common terms:
• MSUD - Maple Syrup Urine Disease
• BCAA - Branched-chain amino acids (leucine, isoleucine, and valine)
• BCKD - Branched-chain alpha-keto acid dehydrogenase (enzyme complex involved in breaking down BCAAs)
• Metabolic crisis - A period when amino acid levels rise quickly, often during illness or stress, requiring urgent clinic guidance

 

Key ideas:
• MSUD affects how the body processes leucine, isoleucine, and valine.
• Without management, levels can rise quickly and become dangerous.
• Many people with MSUD live healthy lives with early treatment and ongoing metabolic follow-up.

 

 

MSUD is typically identified through newborn screening. Most babies with MSUD appear well at birth, and the condition cannot be detected by physical examination alone. Early detection helps families and clinics begin management before toxic levels build up.

 

Without early diagnosis and treatment, MSUD can progress quickly and may lead to metabolic decompensation, seizures, coma, brain injury, and in severe cases, death. If you are concerned about screening results, symptoms, or follow-up testing, contact your metabolic clinic or healthcare team for guidance.

 

Want to learn more?
• CanPKU+ overview: Newborn Screening Overview
• Newborn Screening Ontario: MSUD information

 

 

Lifelong condition:
MSUD is a lifelong condition. Many people with MSUD can live healthy lives with careful management and regular follow-up with a metabolic clinic.

 

How management works:
Management helps prevent leucine, isoleucine, and valine from building up to unsafe levels. Your clinic will guide dietary targets, metabolic formula use, and what to do during illness.

 

Monitoring and labs:
MSUD requires regular monitoring of amino acid levels based on your clinic’s recommendations. Monitoring helps your care team understand trends and adjust a plan over time.

 

Important: Tracking methods can differ by clinic (exchanges vs grams vs total protein vs formula rules). Always follow your clinic’s plan and ask if you are unsure.

 

 

For condition-specific targets and monitoring details, visit your disorder page: MSUD. For practical nutrition support, visit Nourish.

 

 

 

If you are looking for treatment options used in Canada, start here:

Therapies for MSUD MSUD Studies & Trials

Or explore practical food and nutrition support:

Nourish Flourish Life Stages